Hong-Quan Sun1, Zhan-Yu Zhou. 1. Department of Ophthalmology, the Affiliated Hospital of Medical College of Qingdao University, Qingdao 266003, Shandong Province, China.
Abstract
AIM: To investigate the effect of ginsenoside-Rg3 on the expression of vascular endothelial growth factor (VEGF) and tumor necrosis factor-α (TNF-α) in retina with diabetic rats and its roles in preventing neovascularization in diabetes. METHODS: Sixty male Wistar rats were divided into 3 groups randomly: negative control group, diabetic control group and ginsenoside-Rg3 treatment group (5mg/kg, 0.2mg/mL) followed by establishing diabetic model. The expression of VEGF and TNF-α were measured after 8 weeks. RESULTS: There were significant differences among negative control group, diabetic control group and ginsenoside-Rg3 treatment group in the expression of VEGF and TNF-α (F=129.363, 211.992; all the P<0.01). VEGF and TNF-α expression were significantly higher in diabetic control group and ginsenoside-Rg3 treatment group than that in negative control group (P<0.01), with a significant reduction in ginsenoside-Rg3 treatment group than that in diabetic control group (P<0.01). CONCLUSION: Ginsenoside-Rg3 can down-regulate the expression of VEGF and TNF-α in retina, which may interfere in the development of diabetic retinopathy.
AIM: To investigate the effect of ginsenoside-Rg3 on the expression of vascular endothelial growth factor (VEGF) and tumor necrosis factor-α (TNF-α) in retina with diabeticrats and its roles in preventing neovascularization in diabetes. METHODS: Sixty male Wistar rats were divided into 3 groups randomly: negative control group, diabetic control group and ginsenoside-Rg3 treatment group (5mg/kg, 0.2mg/mL) followed by establishing diabetic model. The expression of VEGF and TNF-α were measured after 8 weeks. RESULTS: There were significant differences among negative control group, diabetic control group and ginsenoside-Rg3 treatment group in the expression of VEGF and TNF-α (F=129.363, 211.992; all the P<0.01). VEGF and TNF-α expression were significantly higher in diabetic control group and ginsenoside-Rg3 treatment group than that in negative control group (P<0.01), with a significant reduction in ginsenoside-Rg3 treatment group than that in diabetic control group (P<0.01). CONCLUSION:Ginsenoside-Rg3 can down-regulate the expression of VEGF and TNF-α in retina, which may interfere in the development of diabetic retinopathy.
Authors: T Yuuki; T Kanda; Y Kimura; N Kotajima; J Tamura; I Kobayashi; S Kishi Journal: J Diabetes Complications Date: 2001 Sep-Oct Impact factor: 2.852
Authors: Antonia M Joussen; Vassiliki Poulaki; Wenying Qin; Bernd Kirchhof; Nicholas Mitsiades; Stanley J Wiegand; John Rudge; George D Yancopoulos; Anthony P Adamis Journal: Am J Pathol Date: 2002-02 Impact factor: 4.307
Authors: M Mochizuki; Y C Yoo; K Matsuzawa; K Sato; I Saiki; S Tono-oka; K Samukawa; I Azuma Journal: Biol Pharm Bull Date: 1995-09 Impact factor: 2.233
Authors: Juan Wang; Chunli Cui; Li Fu; Zili Xiao; Nanzi Xie; Yang Liu; Lu Yu; Haifeng Wang; Bangzhen Luo Journal: Mol Med Rep Date: 2016-05-27 Impact factor: 2.952